Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3430908 Target Snapshot

Aurora kinase B/Receptor-type tyrosine-protein kinase · SELECTIVITY GROUP · Homo sapiens

2Compounds
2Assays
1Approved Drugs
2.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P36888. Use UniProt P36888 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P36888 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Protein anchor
Receptor-type tyrosine-protein kinase FLT3

Receptor-type tyrosine-protein kinase FLT3

Review this target as Aurora kinase B/Receptor-type tyrosine-protein kinase, mapped to UniProt P36888. ChEMBL maps the protein component as Receptor-type tyrosine-protein kinase FLT3. Sequence length is 993 aa.

Protein source · UniProt accession via ChEMBL component mapping
UniProt P36888 Protein 993 aa
Open protein block
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Aurora kinase B/Receptor-type tyrosine-protein kinase as ChEMBL target CHEMBL3430908, mapped to UniProt P36888. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Aurora kinase B/Receptor-type tyrosine-protein kinase
SELECTIVITY GROUP · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3430908
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P36888
Receptor-type tyrosine-protein kinase FLT3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Aurora kinase B/Receptor-type tyrosine-protein kinase is the right protein anchor across sources, using UniProt P36888 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelReceptor-type tyrosine-protein kinase FLT3
UniProt AccessionP36888
Component TypeProtein
Sequence Length993 aa

Receptor-type tyrosine-protein kinase FLT3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Aurora kinase B/Receptor-type tyrosine-protein kinase, mapped to UniProt P36888. ChEMBL maps the protein component as Receptor-type tyrosine-protein kinase FLT3. Sequence length is 993 aa.

Mapped IDP36888
Review nameAurora kinase B/Receptor-type tyrosine-protein kinase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC501.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5176837 10.92 Kd 0.012 Preclinical
CHEMBL2105717 8.54 IC50 2.86 Approved
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

CABOZANTINIB
CHEMBL2105717
Approved 2012
Assay Landscape

Assay Landscape

2
Total Assays
2
Tested Compounds
1
Assay Types
Binding — 2 assays, 2 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1 10.9
cell-based format 1 1 8.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine